Members of our Division of Multiple Sclerosis and Neuroimmunology provides excellent patient care as well as clinical and basic research concerning immune diseases of the central nervous system. All of our providers have been named MS Certified Specialists by the Consortium of MS Centers.
What do a speech prosthetic that translates brain signals into speech, retinal scans that detect cognitive impairment, and a promising new form of genetic therapy for Parkinson’s and some forms of dementia have in common? They’re all examples of the 21 peer-reviewed journal articles authored members of the Duke Neurology Department published this November.
This October, members of the Duke Neurology Department contributed to 11 new peer-reviewed journal articles, advancing the fields of clinical and translational neuroscience. Highlights from the past 31 days include descriptions of a new technology that uses retinal scans to detect mild cognitive impairment, a white paper outlining challenges and opportunities for clinical trials in Alzheimer's disease, and genetic analyses that advance our understanding of the origins of Alzheimer’s disease.
The month of September saw 20 new peer-reviewed journal articles articles and one book chapter from members of the Duke Neurology Department.
A new blood-based test for Parkinson’s disease, improved monitoring techniques for epilepsy, and a chapter discussing the use of transcranial magnetic stimulation (TMS) as a noninvasive treatment for dystonia are just a few examples of the latest research from members of the Duke Neurology Department.
Local middle school students visited Duke this August to touch human brains, learn about the U.S. health system, and watch research being conducted in real time, thanks to the BOOST (Building Opportunities and Overtures in Science and Technology) program and the Duke Neurology Department.
Women are three to four times more likely than men to develop multiple sclerosis (MS), a chronic autoimmune disease that affects the brain and spinal cord. Most women with MS are first diagnosed during childbearing years, making family planning an important consideration.
A promising new therapy for brain tumors detailed in the New England Journal of Medicine and a validation of a popular stroke treatment for patients taking vitamin K antagonists published in JAMA are just two highlights of the 15 peer-reviewed journal articles authored by members of the Duke Neurology Department this June.
Members of the Duke Neurology Department shared their advances and insights in neurology education, health disparities, movement disorders, and other areas at the American Academy of Neurology’s (AAN) 75th annual meeting in Boston this week. This year, our faculty, staff, and trainees contributed more to the AAN than in any previous year, contributing to 20 posters and abstracts and six classes or sessions.
Winning the North Carolina Neurological Society's (NCNS) first NeuroBowl trivia contest was just the start for members of the Duke Neurology Department at the NCNS' 2023 annual meeting in Pinehurst, NC, this weekend.
Today is National Women Physician’s Day. This day was marked to honor the birthday of Elizabeth Blackwell, the first woman allowed to enter medical school in the United States. Despite being forced to sit in separately in lectures, being excluded from labs, and facing other forms of discrimination Blackwell graduated first in her class in 1849, and went on to a long and distinguished career, improving physician handwashing, opening the New York Infirmary for Women and Children, and training nurses for Union hospitals during the Civil War.